All of these stocks are among the biggest losers on the Nifty 500 and the BSE Smallcap index. Here’s a look at these reactions:
Sai Life Sciences
Shares of Sai Life Sciences are trading with losses of 11% on Friday after its fourth quarter topline saw subdued growth of only 4% from the same quarter last year.
The fall is despite a 12% increase in Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) and a 470 basis points expansion in the EBITDA margins.
However, both EBITDA and margins were down on a sequential basis.
This is the biggest single-day fall that the stock has seen since its listing in December 2024. The stock though, remains well above its issue price of ₹549.
PN Gadgil
The stock is locked in a 10% lower circuit on Friday, as the company’s EBITDA margin during the quarter narrowed to 3.8% from 5.9% last year.
The stock is down in three out of the last five trading sessions and is set for its biggest single-day fall on record since its listing.
Data Patterns
Data Patterns is also among the top losers on the BSE Smallcap index, trading with losses of 9% on Friday.
The company’s revenue dropped 13% during the March quarter, but both EBITDA and margins saw expansion.
Operational performance received a boost as material cost to sales declined to 27% from 51% earlier. However, they were higher than the 23% significantly.
Even after this drop, the stock is still up 41% this year so far.
HUDCO
Shares of the state-run financier are down 7% on Friday despite record disbursements, strong AUM growth and near-zero NPAs during the March quarter.
Core income went up by 19% from last year, operating income was up 25%, and asset quality also improved sequentially.
The management plans on doubling its balance sheet by financial year 2030 to ₹3 lakh crore. The stock had risen close to 20% in the last one month.
Muthoot Finance
Shares of Muthoot Finance also fell up to 7% on Friday before looking to recover from the initial lows, despite strong growth in both its profit and Net Interest Income during the quarter.
Analysts tracking the stock mostly have a “buy” rating on the stock, calling valuations “attractive.”
